$FENC
FENNEC PHARMACEUTICALS INC.

2012 Q2 Form 10-Q Financial Statement

#000114420412044811 Filed on August 13, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $390.0K $320.0K $400.0K
YoY Change 14.71% -54.93% -24.53%
% of Gross Profit
Research & Development $860.0K $296.0K $510.0K
YoY Change 267.52% -6.03% 75.86%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.250M $296.0K $900.0K
YoY Change 118.53% -6.03% 9.76%
Operating Profit -$1.250M -$616.0K
YoY Change 118.53% -39.67%
Interest Expense $0.00 $0.00 $4.410M
YoY Change -176.43%
% of Operating Profit
Other Income/Expense, Net $648.0K $3.331M
YoY Change 189.29% -41.46%
Pretax Income -$600.0K $2.720M $3.510M
YoY Change 71.43% -41.76% -153.34%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$602.0K $2.715M $3.510M
YoY Change 72.99% -41.85% -153.34%
Net Earnings / Revenue
Basic Earnings Per Share $0.11
Diluted Earnings Per Share -$71.51K $0.11 $420.4K
COMMON SHARES
Basic Shares Outstanding 25.16K shares 25.16M shares
Diluted Shares Outstanding 25.16K shares 25.16M shares

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.590M $4.720M $5.300M
YoY Change -47.28% -5.98% -10.92%
Cash & Equivalents $3.586M $4.719M $5.297M
Short-Term Investments
Other Short-Term Assets $3.000K $14.00K $19.00K
YoY Change -85.0% -80.0% -62.0%
Inventory
Prepaid Expenses $11.00K $24.00K $35.00K
Receivables
Other Receivables
Total Short-Term Assets $3.600M $4.760M $5.350M
YoY Change -47.29% -37.7% -10.68%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 -$3.000K $1.000K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.600M $4.760M $5.350M
Total Long-Term Assets $0.00 -$3.000K $1.000K
Total Assets $3.600M $4.757M $5.351M
YoY Change -47.29% -37.74% -10.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $276.0K $374.0K $342.0K
YoY Change 15.0% -15.0% 26.67%
Accrued Expenses $173.0K $38.00K $52.00K
YoY Change 476.67% -65.45% -74.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.560M $2.160M $5.470M
YoY Change -79.23% -72.73% -49.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.560M $2.160M $5.470M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.555M $2.162M $5.471M
YoY Change -79.29% -72.7% -49.9%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $104.1M $104.0M $104.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.045M $2.595M -$120.0K
YoY Change
Total Liabilities & Shareholders Equity $3.600M $4.757M $5.351M
YoY Change -47.29% -37.74% -10.67%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$602.0K $2.715M $3.510M
YoY Change 72.99% -41.85% -153.34%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$1.133M -$578.0K -$770.0K
YoY Change -163.94% -44.85% 16.67%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $0.00
YoY Change
Cash From Financing Activities $0.00 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$1.133M -578.0K -770.0K
Cash From Investing Activities $0.00 0.000 0.000
Cash From Financing Activities $0.00 0.000 0.000
Net Change In Cash -$1.133M -578.0K -770.0K
YoY Change -163.94% -44.85% 16.67%
FREE CASH FLOW
Cash From Operating Activities -$1.133M -$578.0K -$770.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.133M -$578.0K -$770.0K
YoY Change -163.94% -44.85% 16.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25157618 shares
CY1996Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5023000
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6810000
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
2595000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4719000
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25158000 shares
CY2012Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1106000
CY2012Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18035000 shares
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38117000
CY2012Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
2045000
CY2012Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2012Q2 us-gaap Liabilities
Liabilities
1555000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
276000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11000
CY2012Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
103267000
CY2012Q2 us-gaap Assets
Assets
3600000
CY2012Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3473000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3600000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3586000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25158000 shares
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
173000
CY2012Q2 us-gaap Cash
Cash
4000
CY2012Q2 us-gaap Cash
Cash
113000
CY2012Q2 us-gaap Contractual Obligation
ContractualObligation
936000
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
65952000
CY2012Q2 adhxf Contractual Obligations Current
ContractualObligationsCurrent
436000
CY2012Q2 adhxf Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
1.44
CY2012Q2 adhxf Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms
P3Y
CY2012Q2 adhxf Contractual Obligation Due Year One Through Year Three
ContractualObligationDueYearOneThroughYearThree
500000
CY1996Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY1997Q2 us-gaap Stockholders Equity
StockholdersEquity
-37000
CY1998Q2 us-gaap Stockholders Equity
StockholdersEquity
-435000
CY1999Q2 us-gaap Stockholders Equity
StockholdersEquity
242000
CY2000Q2 us-gaap Stockholders Equity
StockholdersEquity
47000
CY2001Q2 us-gaap Stockholders Equity
StockholdersEquity
9792000
CY2002Q2 us-gaap Stockholders Equity
StockholdersEquity
6071000
CY2003Q2 us-gaap Stockholders Equity
StockholdersEquity
698000
CY2004Q2 us-gaap Stockholders Equity
StockholdersEquity
20454000
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
16654000
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
11077000
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1268000
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
14148000
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
3053000
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
406000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-4926000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5947000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38065000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-120000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25158000 shares
CY2011Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5077000
CY2011Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2011Q4 us-gaap Liabilities
Liabilities
5471000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
342000
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35000
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
105380000
CY2011Q4 us-gaap Assets
Assets
5351000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5351000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5297000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25158000 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
65952000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1593000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
549000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
5905000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9000
us-gaap Other Noncash Expense
OtherNoncashExpense
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1823000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
49000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
882000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1044000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158000 shares
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
107677000 shares
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2566000
us-gaap Operating Expenses
OperatingExpenses
1593000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
3000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158000 shares
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
us-gaap Revenues
Revenues
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
285000
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
49000
us-gaap Net Income Loss
NetIncomeLoss
4321000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5914000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
139000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Severance Costs
SeveranceCosts
0
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5905000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
us-gaap Interest Expense
InterestExpense
0
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
adhxf Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
2566000
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0
dei Trading Symbol
TradingSymbol
ADHXF
dei Entity Registrant Name
EntityRegistrantName
ADHEREX TECHNOLOGIES INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001211583
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158000 shares
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-1867000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Share Based Compensation
ShareBasedCompensation
17000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1157000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3971000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8000
us-gaap Other Noncash Expense
OtherNoncashExpense
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1711000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1711000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
710000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158000 shares
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0
us-gaap Operating Expenses
OperatingExpenses
1867000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
us-gaap Revenues
Revenues
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-96000
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35000
us-gaap Net Income Loss
NetIncomeLoss
2112000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3979000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"><b>Use of estimates</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#xA0;</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in these unaudited interim consolidated financial statements. Actual results could differ from these estimates. In the opinion of management, these unaudited interim consolidated financial statements include all normal and recurring adjustments, considered necessary for the fair presentation of the Company&#x2019;s financial position at June 30, 2012, and to state fairly the results for the periods presented. The most significant estimates included in these financial statements are the derivative instruments described in Note 3. There were significant changes in their valuation during the quarter.</p> </div>
us-gaap Severance Costs
SeveranceCosts
0
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3971000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
us-gaap Interest Expense
InterestExpense
0
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
adhxf Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
0
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1392000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
493000
us-gaap Net Income Loss
NetIncomeLoss
-6594000
CY2010Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y
CY2010Q2 adhxf Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.25 pure
CY2011Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio
StockholdersEquityNoteStockSplitConversionRatio
18 pure
CY1997 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY1997 us-gaap Net Income Loss
NetIncomeLoss
-37000
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-398000
CY1999 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1615000
CY1999 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-958000
CY1999 adhxf Stock Issued During Period Value Exchange Of Owners Equity
StockIssuedDuringPeriodValueExchangeOfOwnersEquity
0
CY2001 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
182000
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-2524000
CY2002 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-3732000
CY2003 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2003 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-159000
CY2003 us-gaap Dividends Cash
DividendsCash
158000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-17795000
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1058000
CY2003 adhxf Stated Capital Adjustment
StatedCapitalAdjustment
0
CY2005 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000
CY2005 us-gaap Stockholders Equity Other
StockholdersEquityOther
141000
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-13871000
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-16440000
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-13357000
CY2007 adhxf Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
694000
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-3012000
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-7824000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
4685000
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
793000
CY2000 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16000
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-1605000
CY2000 adhxf Equity Rights Offering
EquityRightsOffering
-171000
CY2004 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2004 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-219000
CY2004 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
18000
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-6872000
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1983000
CY2004 adhxf Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
-22000
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-13600000
us-gaap Operating Income Loss
OperatingIncomeLoss
-112492000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
22791000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
544000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
65000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
68000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000
us-gaap Share Based Compensation
ShareBasedCompensation
10112000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
209000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
115000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
68250000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
8792000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13094000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2880000
us-gaap Other Noncash Expense
OtherNoncashExpense
1187000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1404000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-83754000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1483000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1440000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3586000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31259000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
264000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88445000
us-gaap Operating Expenses
OperatingExpenses
112492000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1283000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-36000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
465000
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
24000
us-gaap Revenues
Revenues
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
10000
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
35000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
640000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
931000
us-gaap Net Income Loss
NetIncomeLoss
-101858000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10634000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
87000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3017000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
378000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
22148000
us-gaap Severance Costs
SeveranceCosts
168000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8792000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
166000
us-gaap Interest Expense
InterestExpense
19000
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
190000
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
412000
adhxf Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
86443000
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
497000
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-572000
CY2011Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2011Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2011Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2011Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2011Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.02500 pure
CY2011Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2011Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2011Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2011Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
234000
CY2011Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
225000
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
CY2011Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-1000
CY2011Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2011Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
CY2011Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2011Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2011Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1772000
CY2011Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2011Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
49000
CY2011Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2011Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1787000
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
338000
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158000 shares
CY2011Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2011Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
572000
CY2011Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.347 pure
CY2011Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
13000
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158000 shares
CY2011Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2011Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
CY2011Q2 us-gaap Revenues
Revenues
0
CY2011Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
CY2011Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-2309000
CY2011Q2 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
CY2011Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0259 pure
CY2011Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
49000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-348000
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
224000
CY2011Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2011Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2011Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
15000
CY2011Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2011Q2 us-gaap Severance Costs
SeveranceCosts
0
CY2011Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
225000
CY2011Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2011Q2 us-gaap Interest Expense
InterestExpense
0
CY2011Q2 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
CY2011Q2 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
CY2011Q2 adhxf Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
0
CY2011Q2 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
2715000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1250000
CY2012Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2012Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2012Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2012Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.01125 pure
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
17000
CY2012Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2012Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
860000
CY2012Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
645000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
CY2012Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3000
CY2012Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1133000
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52000
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1133000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.32 pure
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
390000
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158000 shares
CY2012Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.33 pure
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
1250000
CY2012Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158000 shares
CY2012Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2012Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
CY2012Q2 us-gaap Revenues
Revenues
0
CY2012Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
CY2012Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-62000
CY2012Q2 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
CY2012Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0125 pure
CY2012Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-602000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
648000
CY2012Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2012Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0
CY2012Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2012Q2 us-gaap Severance Costs
SeveranceCosts
0
CY2012Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
645000
CY2012Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2012Q2 us-gaap Interest Expense
InterestExpense
0
CY2012Q2 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
CY2012Q2 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
CY2012Q2 adhxf Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
0
CY2012Q2 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0

Files In Submission

Name View Source Status
0001144204-12-044811-index-headers.html Edgar Link pending
0001144204-12-044811-index.html Edgar Link pending
0001144204-12-044811.txt Edgar Link pending
0001144204-12-044811-xbrl.zip Edgar Link pending
adhxf-20120630.xml Edgar Link completed
adhxf-20120630.xsd Edgar Link pending
adhxf-20120630_cal.xml Edgar Link unprocessable
adhxf-20120630_def.xml Edgar Link unprocessable
adhxf-20120630_lab.xml Edgar Link unprocessable
adhxf-20120630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v318511_10q.htm Edgar Link pending
v318511_ex10-1.htm Edgar Link pending
v318511_ex10-2.htm Edgar Link pending
v318511_ex31-1.htm Edgar Link pending
v318511_ex31-2.htm Edgar Link pending
v318511_ex32-1.htm Edgar Link pending
v318511_ex99-1.htm Edgar Link pending